Pyrroliidinobenzoic acid inhibitors of influenza virus neuraminidase: Modifications of essential pyrrolidinone ring substituents

被引:30
作者
Brouillette, WJ
Bajpai, SN
Ali, SM
Velu, SE
Atigadda, VR
Lommer, BS
Finley, JB
Luo, M
Air, GM
机构
[1] Univ Alabama, Dept Chem, Birmingham, AL 35294 USA
[2] Univ Alabama, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA
[4] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA
关键词
D O I
10.1016/S0968-0896(03)00271-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We recently reported the first benzoic acid, 1-[4-carboxy-2-(3-pentylamino)phenyl]-5,5-bis(hydroxymethyl)pyrrolidin-2-one (8), that is a potent inhibitor of avian influenza A neuraminidase (N9) and, unlike other reported potent neuraminidase inhibitors, does not contain a basic aliphatic amine or guanidine nor a simple N-acetyl grouping. However, 8 was a poor inhibitor of influenza B neuraminidase. In the present study we further evaluated 8 as an inhibitor of human influenza A NA isolates, and it was effective against N2 NA but found to be 160-fold less active against N1 NA. We also synthesized analogues of 8 involving moderate modifications of essential substituents on the pyrrolidinone ring. Specifically, the aminomethyl (9), hydroxyethyl (10), and aminoethyl (11) analogues were prepared. Only the most conservative change (compound 9) resulted in continued effective inhibition of influenza A, in addition to a noteworthy increase in the activity of 9 for N1 NA. The effectiveness of 9 against influenza B neuraminidase was furthermore improved 10-fold relative to 8, but this activity remained 50-fold poorer than for type A NA. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2739 / 2749
页数:11
相关论文
共 19 条
  • [1] THE NEURAMINIDASE OF INFLUENZA-VIRUS
    AIR, GM
    LAVER, WG
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1989, 6 (04): : 341 - 356
  • [2] Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent
    Atigadda, VR
    Brouillette, WJ
    Duarte, F
    Ali, SM
    Babu, YS
    Bantia, S
    Chand, P
    Chu, N
    Montgomery, JA
    Walsh, DA
    Sudbeck, EA
    Finley, J
    Luo, M
    Air, GM
    Laver, GW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (13) : 2332 - 2343
  • [3] AYMARDHENRY M, 1973, B WORLD HEALTH ORGAN, V48, P199
  • [4] BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design
    Babu, YS
    Chand, P
    Bantia, S
    Kotian, P
    Dehghani, A
    El-Kattan, Y
    Lin, TH
    Hutchison, TL
    Elliott, AJ
    Parker, CD
    Ananth, SL
    Horn, LL
    Laver, GW
    Montgomery, JA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (19) : 3482 - 3486
  • [5] COUCH RB, 1995, DIAGNOSTIC PROCEDURE
  • [6] Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza
    Hayden, FG
    Treanor, JJ
    Betts, RF
    Lobo, M
    Esinhart, JD
    Hussey, EK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (04): : 295 - 299
  • [7] STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA-VIRUS NEURAMINIDASE
    JEDRZEJAS, MJ
    SINGH, S
    BROUILLETTE, WJ
    LAVER, WG
    AIR, GM
    LUO, M
    [J]. BIOCHEMISTRY, 1995, 34 (10) : 3144 - 3151
  • [8] Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: Design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity
    Kim, CU
    Lew, W
    Williams, MA
    Liu, HT
    Zhang, LJ
    Swaminathan, S
    Bischofberger, N
    Chen, MS
    Mendel, DB
    Tai, CY
    Laver, WG
    Stevens, RC
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (04) : 681 - 690
  • [9] LAVER WG, 1990, FUNDAMENTAL TECHNIQU
  • [10] SELECTION AND CHARACTERIZATION OF A NEURAMINIDASE-MINUS MUTANT OF INFLUENZA-VIRUS AND ITS RESCUE BY CLONED NEURAMINIDASE GENES
    LIU, CG
    AIR, GM
    [J]. VIROLOGY, 1993, 194 (01) : 403 - 407